Li, J., Zhang, H., Sun, P., Gu, F., & Liu, Z. (2013). Bevacizumab vs ranibizumab for neovascular age-related macular degeneration in Chinese patients. International Journal of Ophthalmology Press.
Citación estilo ChicagoLi, Jun, Han Zhang, Peng Sun, Feng Gu, y Zhe-Li Liu. Bevacizumab Vs Ranibizumab for Neovascular Age-related Macular Degeneration in Chinese Patients. International Journal of Ophthalmology Press, 2013.
Cita MLALi, Jun, et al. Bevacizumab Vs Ranibizumab for Neovascular Age-related Macular Degeneration in Chinese Patients. International Journal of Ophthalmology Press, 2013.
Precaución: Estas citas no son 100% exactas.